SageMedic

SageMedic is a functional precision oncology company that develops and commercializes the SAGE Oncotest™, an AI-augmented 3D micro-tumor assay. The platform uses a patient's live tumor tissue to create hundreds of micro-tumor replicates, which are then tested against a wide range of FDA-approved therapies to identify the most effective treatment within 7-10 days. By preserving the tumor microenvironment and heterogeneity, SageMedic aims to overcome the limitations of genomic testing and provide actionable insights for late-stage cancer patients. The company operates a CLIA-certified laboratory in Redwood City, California, and collaborates with oncologists to personalize cancer care.